SOTAX
The ability to flexibly respond to change in today’s fast-paced pharmaceutical environment can make the difference between success and failure. Fast time-to-market requirements — outsourcing, relocations, shift of manufacturing capacities and short return on investment considerations — ask for equally flexible testing solutions in R&D and QC laboratories. According to the SOTAX Group, its brand new, fully modular and scalable Xtend dissolution line concept is 100% based on this basic premise and allows laboratory scientists to tailor dissolution testing to both their current and future needs, making their investment future-proof.
This concept consists of new individual and standardised Xtend modules such as the AT dissolution bath, the CP pump, the FS filter station and the SAM sample manager, which can be combined for different automation requirements, from manual bath to semi- and fully automated dissolution system.
Irrespective of the chosen configuration, all modules and components of the Xtend dissolution line are robust as they are designed for the most demanding conditions of a fully automated system running 24 hours per day.
The Xtend dissolution line also aims to simplify method transfer, to make scale-up from R&D to QC with different throughput requirements and changing workloads easier. From qualification to writing SOPs, scientists can keep in place what is already used, described and validated.
SOTAX AG, www.sotax.com.